| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.009 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.02 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.2 | 0.02 |